ArticleFrontiers in immunology2020

Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.

Pedro A RechePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.